Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort.

Authors : Kjellin, Midori¹; Wesslén, Terése²; Löfblad, Erik²

Source: Upsala Journal of Medical Sciences. Mar2018, Vol. 123 Issue 1, p50-56. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Efficacy and safety of telaprevir with natural human interferon‐β and ribavirin in Japanese chronic hepatitis C patients with depression.

Authors : Kumada, Hiromitsu¹ ; Mochida, Satoshi²; Nakamuta, Makoto³

Source: Hepatology Research. Feb2018, Vol. 48 Issue 2, p184-192. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A strategy for early-risk predictions of clinical drug–drug interactions involving the GastroPlus DDI module for time-dependent CYP inhibitors.

Authors : Sohlenius-Sternbeck, Anna-Karin¹ (AUTHOR) ; Meyerson, Gabrielle¹ (AUTHOR); Hagbjörk, Ann-Louise¹ (AUTHOR)

Source: Xenobiotica. Apr2018, Vol. 48 Issue 4, p348-356. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effectiveness and safety of protease inhibitors for the Hepatitis C treatment in a hospital of South Brazil: real life data.

Authors : Mattana, Aline Bianca Borba¹ ; Schwambach, Karin Hepp¹; Feltrin, Alberi Adolfo²

Source: Revista de Ciências Farmacêuticas Básica e Aplicada. 2018, Vol. 39, p1-7. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Teledermatologist expert skin advice: A unique model of care for managing skin disorders and adverse drug reactions in hepatitis C patients.

Authors : Charlston, Samuel¹ ; Siller, Gregory^2,3,4

Source: Australasian Journal of Dermatology. Nov2018, Vol. 59 Issue 4, p315-317. 3p. 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy.

Authors : Hunyady, Béla^1,2 ; Abonyi, Margit³; Gerlei, Zsuzsanna⁴

Source: Clinical & Experimental Hepatology. 2018, Vol. 4 Issue 2, p83-90. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.

Authors : Janczewska, Ewa¹ ; Zarębska-Michaluk, Dorota² ; Berak, Hanna³

Source: BMC Infectious Diseases. 11/16/2018, Vol. 18 Issue 1, p1-9. 9p. 1 Diagram, 3 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Levofloxacin and Ibuprofen Leading to Steven Johnson Syndrome: A Dermatological Emergency.

Authors : Zafar, Muhammad Raheel¹; Ahmed, Mohsin¹; Sabir, Muhammad Sharjeel¹

Source: Journal of Rawalpindi Medical College. Jul-Sep2018, Vol. 22 Issue 3, p298-299. 2p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Antiviral Medications, Part 4: Evidence-Based Treatment of Hepatitis C.

Authors : Felicilda-Reynaldo, Rhea Faye D.¹

Source: MEDSURG Nursing. Jan/Feb2018, Vol. 27 Issue 1, p49-52. 4p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Chronic Hepatitis C Treatment with New Antiviral Agents.

Authors : KANDEMİR, Özlem¹

Source: Mediterranean Journal of Infection, Microbes & Antimicrobials. 2018, p1-16. 16p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort.

Efficacy and safety of telaprevir with natural human interferon‐β and ribavirin in Japanese chronic hepatitis C patients with depression.

A strategy for early-risk predictions of clinical drug–drug interactions involving the GastroPlus DDI module for time-dependent CYP inhibitors.

Effectiveness and safety of protease inhibitors for the Hepatitis C treatment in a hospital of South Brazil: real life data.

Teledermatologist expert skin advice: A unique model of care for managing skin disorders and adverse drug reactions in hepatitis C patients.

Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy.

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.

Levofloxacin and Ibuprofen Leading to Steven Johnson Syndrome: A Dermatological Emergency.

Antiviral Medications, Part 4: Evidence-Based Treatment of Hepatitis C.

Chronic Hepatitis C Treatment with New Antiviral Agents.

اتصل بنا

اتبع